COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE
www.patentreply.ai/tools/patent-expiration/US9457070Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.
Learn how PTE is calculatedCompositions, Methods And Uses Of Alpha 1-antitrypsin For Early Intervention In Bone Marrow Transplantation And Treatment Of Graft Versus Host Disease
Application No. 13209349
June 7, 2026
Expired 78 days agoEarliest effective filing
Jun 7, 2006
+ 20 years
Jun 7, 2026
PTA +404d
Jul 16, 2027
TD cap (US 9884096)
Jun 7, 2026
Final
Jun 7, 2026
Filing Date
August 12, 2011
Earliest Effective Filing
June 7, 2006
Issue Date
October 4, 2016
PTA
+404 days
Base Expiry (before PTA)
June 7, 2026
Could not resolve calculation details
Compositions, Methods And Uses Of Alpha 1-antitrypsin For Early Intervention In Bone Marrow Transplantation And Treatment Of Graft Versus Host Disease
Filing Date
Aug 12, 2011
Earliest Effective Filing
Jun 7, 2006
Issue Date
Oct 4, 2016
PTA
+404 days
Calculated Expiration
Jul 16, 2027
Compositions And Methods Related To Graft Versus Host Disease And Treatments Thereof
Filing Date
Apr 30, 2014
Earliest Effective Filing
Jun 7, 2006
Issue Date
Feb 6, 2018
PTA
0 days
Calculated Expiration
Jun 7, 2026
Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.